Carcinoma, Hepatocellular
Showing NaN - NaN of 45
Carcinoma, Hepatocellular Trial in Seoul (Needle guiding robot)
Unknown status
- Carcinoma, Hepatocellular
- Needle guiding robot
-
Seoul, Korea, Republic ofAsan Medical Center
Sep 6, 2018
Carcinoma, Hepatocellular Trial in Worldwide (Nexavar (Sorafenib, BAY43-9006), Placebo)
Completed
- Carcinoma, Hepatocellular
- Nexavar (Sorafenib, BAY43-9006)
- Placebo
-
Birmingham, Alabama
- +198 more
Jul 11, 2018
Remnant Liver Function Using Primovist-enhanced MRI Before
Completed
- Carcinoma, Hepatocellular
- Liver Dysfunction
- Gd-EOB-DTPA
- MRI
-
Hwasun-Gun, Cheonnam Province, Korea, Republic of
- +3 more
Mar 22, 2018
Carcinoma, Hepatocellular Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)
Completed
- Carcinoma, Hepatocellular
- Sorafenib (Nexavar, BAY43-9006)
- Placebo
-
La Jolla, California
- +106 more
Jul 18, 2017
Carcinoma, Hepatocellular Trial in Seoul (5-FU, Mitomycin, sorafenib)
Terminated
- Carcinoma, Hepatocellular
- 5-FU
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 24, 2017
Carcinoma, Hepatocellular Trial in Korea, Republic of, Taiwan (Sorafenib, BIBF 1120)
Completed
- Carcinoma, Hepatocellular
- Sorafenib
- BIBF 1120
-
Seoul, Korea, Republic of
- +15 more
Feb 9, 2016
Carcinoma, Hepatocellular Trial in Canada, Korea, Republic of, United States (JX-594: Recombinant vaccinia virus (TK-deletion
Completed
- Carcinoma, Hepatocellular
- JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)
-
La Jolla, California
- +8 more
Jan 6, 2016
Carcinoma, Hepatocellular, Liver Tumors Trial in Worldwide (drug, device, procedure)
Completed
- Carcinoma, Hepatocellular
- Liver Neoplasms
- Talaporfin sodium
- +3 more
-
Zagreb, Croatia
- +33 more
Jan 22, 2015
Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Sorafenib (Nexavar, BAY43-9006), Placebo)
Completed
- Carcinoma, Hepatocellular
- Sorafenib (Nexavar, BAY43-9006)
- Placebo
-
Hefei, Anhui, China
- +22 more
Mar 26, 2014
Hepatocellular Carcinoma and Dysplastic Nodules in Cirrhotic
Withdrawn
- Liver Cirrhosis
- Carcinoma, Hepatocellular
-
Seoul, Korea, Republic of
- +1 more
Jan 26, 2014
Carcinoma, Hepatocellular Trial in Japan, Korea, Republic of (Sorafenib (Nexavar, BAY43-9006), Placebo)
Completed
- Carcinoma, Hepatocellular
- Sorafenib (Nexavar, BAY43-9006)
- Placebo
-
Nagoya, Aichi, Japan
- +74 more
Nov 26, 2013
Carcinoma, Hepatocellular Trial in Worldwide (BAY86-9766 MEK Inhibitor + Sorafenib)
Completed
- Carcinoma, Hepatocellular
- BAY86-9766 MEK Inhibitor + Sorafenib
-
Shatin, New Territories, Hong Kong
- +14 more
Sep 5, 2013
Carcinoma, Hepatocellular Trial in Worldwide (sunitinib malate, sorafenib)
Terminated
- Carcinoma, Hepatocellular
- sunitinib malate
- sorafenib
-
Fountain Valley, California
- +170 more
Dec 7, 2012
Carcinoma, Hepatocellular Trial in Seoul (TACE (Transcatheter Arterial Chemoembolization ))
Completed
- Carcinoma, Hepatocellular
- TACE (Transcatheter Arterial Chemoembolization )
-
Seoul, Korea, Republic ofNational Cancer Center
May 29, 2012
Carcinoma, Hepatocellular Trial in Seoul (Oxaliplatin, Fluorouracil, Leucovorin)
Completed
- Carcinoma, Hepatocellular
- Oxaliplatin
- +2 more
-
Seoul, Korea, Republic ofSanofi-Aventis Administrative Office
Jun 27, 2011
Carcinoma, Hepatocellular Trial in Worldwide (Oxaliplatin + 5-Fluorouracil/Leucovorin, Doxorubicin)
Completed
- Carcinoma, Hepatocellular
- Oxaliplatin + 5-Fluorouracil/Leucovorin
- Doxorubicin
-
Shanghai, China
- +3 more
Sep 17, 2010
Carcinoma, Hepatocellular Trial in Worldwide (Irinotecan plus capecitabine)
Completed
- Carcinoma, Hepatocellular
- Irinotecan plus capecitabine
-
Shanghai, China
- +8 more
Apr 2, 2008